BioCentury
ARTICLE | Financial News

ChemoCentryx raises $60 million in follow-on

April 18, 2013 12:28 AM UTC

ChemoCentryx Inc. (NASDAQ:CCXI) raised $60 million through the sale of 5 million shares at $12 in a follow-on underwritten by JPMorgan; Goldman Sachs; Cowen; and Stifel Nicolaus Weisel. ChemoCentryx proposed the offering late Monday, when its stock price was $13.58. On Wednesday, the company was off $0.22 to $12.04. ...